| $385M | ||
| $350M | ||
| $215M | ||
| $100M | ||
| $83M | ||
| $63M |
Buys | $0 | 0 | 0 |
Sells | $134,879,226 | 31 | 100 |
| Freidin Aaron | Chief Financial Officer | 0 | $0 | 9 | $7.27M | $-7.27M |
| Ofman Joshua J. | President | 0 | $0 | 13 | $14.97M | $-14.97M |
| RAGUSA ROBERT P | Chief Executive Officer | 0 | $0 | 7 | $15.95M | $-15.95M |
| DING CHUN R | 10 percent owner | 0 | $0 | 1 | $16.83M | $-16.83M |
| ILLUMINA, INC. | 10 percent owner | 0 | $0 | 1 | $79.85M | $-79.85M |
GRAIL, Inc., a biotechnology company, focuses on developing technologies for early cancer detection. The company develops Galleri, a screening test for asymptomatic individuals over 50 years of age; and DAC, a diagnostic aid for cancer tests to accelerate diagnostic resolution for patients for whom there is a clinical suspicion of cancer. It is also developing minimal residual disease and other post-diagnostic tests. The company was incorporated in 2015 and is based in Menlo Park, California. GRAIL, Inc. operates as a former subsidiary of Illumina, Inc.
Over the last 12 months, insiders at GRAIL, Inc. have bought $0 and sold $134.88M worth of GRAIL, Inc. stock.
On average, over the past 5 years, insiders at GRAIL, Inc. have bought $0 and sold $67.62M worth of stock each year.
There was no buying activity among insiders over the last 12 months.
| 2026-04-08 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 123,502 0.3058% | $49.92 | $6.16M | -1.26% | |
| 2026-04-08 | Sale | Ofman Joshua J. | President | 61,665 0.1527% | $49.92 | $3.08M | -1.26% | |
| 2026-04-08 | Sale | Freidin Aaron | Chief Financial Officer | 45,806 0.1134% | $49.92 | $2.29M | -1.26% | |
| 2026-03-09 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 7,461 0.0182% | $47.89 | $357,296 | -2.21% | |
| 2026-03-09 | Sale | Ofman Joshua J. | President | 2,937 0.0072% | $47.89 | $140,650 | -2.21% | |
| 2026-03-09 | Sale | Freidin Aaron | Chief Financial Officer | 2,492 0.0061% | $47.89 | $119,340 | -2.21% | |
| 2026-03-05 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 980 0.0026% | $53.01 | $51,950 | -5.85% | |
| 2026-03-05 | Sale | Ofman Joshua J. | President | 690 0.0018% | $53.01 | $36,577 | -5.85% | |
| 2026-03-05 | Sale | Freidin Aaron | Chief Financial Officer | 655 0.0017% | $53.01 | $34,722 | -5.85% | |
| 2026-03-02 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 37,504 0.0907% | $50.17 | $1.88M | -6.33% | |
| 2026-03-02 | Sale | Ofman Joshua J. | President | 17,002 0.0411% | $50.16 | $852,848 | -6.33% | |
| 2026-03-02 | Sale | Freidin Aaron | Chief Financial Officer | 9,573 0.0231% | $50.17 | $480,244 | -6.33% | |
| 2025-12-03 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 40,000 0.1033% | $95.24 | $3.81M | -11.21% | |
| 2025-12-03 | Sale | Ofman Joshua J. | President | 13,000 0.0353% | $100.00 | $1.3M | -11.21% | |
| 2025-12-03 | Sale | Freidin Aaron | Chief Financial Officer | 25,000 0.0672% | $99.15 | $2.48M | -11.21% | |
| 2025-11-17 | Sale | ILLUMINA, INC. | 10 percent owner | 1M 2.166% | $79.85 | $79.85M | +7.24% | |
| 2025-11-17 | Sale | Freidin Aaron | Chief Financial Officer | 1,697 0.0036% | $79.20 | $134,402 | +7.24% | |
| 2025-10-16 | Sale | Ofman Joshua J. | President | 6,114 0.0136% | $82.01 | $501,409 | +1.70% | |
| 2025-10-15 | Sale | RAGUSA ROBERT P | Chief Executive Officer | 7,239 0.0135% | $68.88 | $498,622 | +15.80% | |
| 2025-10-15 | Sale | Ofman Joshua J. | President | 8,865 0.0183% | $76.03 | $673,985 | +15.80% |
| Increased Positions | 235 | +64.38% | 8M | +33.97% |
| Decreased Positions | 140 | -38.36% | 3M | -13.41% |
| New Positions | 112 | New | 3M | New |
| Sold Out Positions | 43 | Sold Out | 537,007 | Sold Out |
| Total Postitions | 460 | +26.03% | 30M | +20.56% |